Electrophysiological substrate and ablation outcomes in atrial fibrillation with hypertrophic cardiomyopathy: a propensity-matched multicenter study
Abrar, Umair Ghaffar, Fazal Zuhaid, Muhammad Afzaal, Huzaifa Bin Abbasi, Palwasha Iqbal, Muhammad Hasnain Oʻgʻli, Moʻminov Jahongir Zokirjon Safi, Sifat Ullah
Abrar, Umair
Ghaffar, Fazal
Zuhaid, Muhammad
Afzaal, Huzaifa Bin
Abbasi, Palwasha
Iqbal, Muhammad Hasnain
Oʻgʻli, Moʻminov Jahongir Zokirjon
Safi, Sifat Ullah
Abstract
BACKGROUND: Atrial fibrillation (AF) is the most common sustained arrhythmia in hypertrophic cardiomyopathy (HCM), yet the intracardiac electrophysiological substrate underlying recurrence following catheter ablation remains poorly characterized. We compared the atrial substrate and ablation outcomes between HCM-AF patients and propensity-score-matched lone AF controls.
METHODS: This multicenter retrospective study was conducted across three tertiary centers in Pakistan (2015-2023). Of 841 screened patients, 143 HCM-AF patients were matched 1:1 with 143 lone AF controls on 14 covariates. Left atrial (LA) electroanatomic voltage mapping, intracardiac electrophysiological variables, and AF inducibility were compared. Primary endpoints were LA low-voltage area (LVA) burden, AF inducibility, and 12-month freedom from recurrence post-ablation.
RESULTS: HCM-AF patients had greater LVA burden (29.7% ± 17.4% vs. 11.8% ± 9.7%, < 0.001), wider AERP dispersion (41.3 ± 15.7 vs. 18.6 ± 9.4 ms, < 0.001), and higher AF inducibility (81.8% vs. 58.7%, < 0.001). Among 261 ablated patients, 12-month freedom from recurrence was 51.7% in HCM-AF versus 73.9% in lone AF ( = 0.001). LVA burden (aHR 1.41 per 10% increase), HCM diagnosis (aHR 2.19), non-paroxysmal AF (aHR 1.88), and AERP dispersion ≥ 30 ms (aHR 1.67) independently predicted recurrence. Latent class analysis identified three EP phenotype clusters with divergent outcomes: 81.7%, 61.4%, and 31.9% recurrence-free survival ( < 0.001). Complication rates were comparable (4.7% vs. 2.2%, = 0.33).
CONCLUSION: HCM-AF is associated with a more arrhythmogenic atrial substrate and inferior ablation outcomes compared with lone AF. LVA burden is the strongest predictor of recurrence. EP substrate phenotyping may enable meaningful risk stratification in this population.
MIDER Authors
Affiliations
Orthopaedic and Medical Institute (Pvt) Ltd, Karachi, Pakistan; King Fahd Military Medical Complex, Dhahran, Saudi Arabia; South Warwickshire University NHS Foundation Trust; Rai Medical College, Sargodha, Pakistan; et al.
Date
2026-05-23
Type
Article
Collections
Citation
Abrar U, Ghaffar F, Zuhaid M, Afzaal HB, Abbasi P, Iqbal MH, Oʻgʻli MJZ, Safi SU. Electrophysiological Substrate and Ablation Outcomes in Atrial Fibrillation With Hypertrophic Cardiomyopathy: A Propensity-Matched Multicenter Study. J Arrhythm. 2026 May 23;42(3):e70364. doi: 10.1002/joa3.70364.
Journal / Source Title
PMID
Publisher
Publisher’s URL
Publisher’s statement
© 2026 The Author(s). Journal of Arrhythmia published by John Wiley & Sons Australia, Ltd on behalf of Japanese Heart Rhythm Society. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.